323 related articles for article (PubMed ID: 24305518)
61. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.
Frampton JE; Scott LJ
Am J Cardiovasc Drugs; 2009; 9(5):309-30. PubMed ID: 19791840
[TBL] [Abstract][Full Text] [Related]
62. High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension.
Andreadis EA; Tsourous GI; Marakomichelakis GE; Katsanou PM; Fotia ME; Vassilopoulos CV; Diamantopoulos EJ
J Hum Hypertens; 2005 Jun; 19(6):491-6. PubMed ID: 15759025
[TBL] [Abstract][Full Text] [Related]
63. Single-pill telmisartan and amlodipine: a rational combination for the treatment of hypertension.
Suárez C
Drugs; 2011 Dec; 71(17):2295-305. PubMed ID: 22085386
[TBL] [Abstract][Full Text] [Related]
64. The importance of 24-hour ambulatory blood pressure monitoring in patients at risk of cardiovascular events.
Redon J
High Blood Press Cardiovasc Prev; 2013 Mar; 20(1):13-8. PubMed ID: 23532740
[TBL] [Abstract][Full Text] [Related]
65. Comparative effects of telmisartan in the treatment of hypertension.
White WB
J Clin Hypertens (Greenwich); 2002; 4(4 Suppl 1):20-5. PubMed ID: 12147925
[TBL] [Abstract][Full Text] [Related]
66. An effectiveness study comparing algorithm-based antihypertensive therapy with previous treatments using conventional and ambulatory blood pressure measurements.
Weber MA; White WB; Giles TD; Bakris GL; Neutel JM; Smith DH; Davidai G
J Clin Hypertens (Greenwich); 2006 Apr; 8(4):241-50; quiz 251-2. PubMed ID: 16596026
[TBL] [Abstract][Full Text] [Related]
67. Dose Timing of an Angiotensin II Receptor Blocker/Calcium Channel Blocker Combination in Hypertensive Patients With Paroxysmal Atrial Fibrillation.
Kario K; Hoshide S; Uchiyama K; Yoshida T; Okazaki O; Noshiro T; Aoki H; Mizuno H; Matsumoto Y
J Clin Hypertens (Greenwich); 2016 Oct; 18(10):1036-1044. PubMed ID: 26989846
[TBL] [Abstract][Full Text] [Related]
68. The 24-hour blood pressure pattern: does it have implications for morbidity and mortality?
Weber MA
Am J Cardiol; 2002 Jan; 89(2A):27A-33A. PubMed ID: 11835909
[TBL] [Abstract][Full Text] [Related]
69. The combination of amlodipine and angiotensin receptor blocker or diuretics in high-risk hypertensive patients: rationale, design and baseline characteristics.
Wang W; Ma L; Zhang Y; Deng Q; Liu M; Liu L
J Hum Hypertens; 2011 Apr; 25(4):271-7. PubMed ID: 20445570
[TBL] [Abstract][Full Text] [Related]
70. Comparative antihypertensive efficacy of angiotensin receptor blocker-based treatment in African-American and white patients.
Bakris GL; Smith DH; Giles TD; White WB; Davidai G; Weber MA
J Clin Hypertens (Greenwich); 2005 Oct; 7(10):587-95; quiz 596-7. PubMed ID: 16227761
[TBL] [Abstract][Full Text] [Related]
71. [Current position of a fixed combination telmisartan with amlodipine in treatment of essential arterial hypertension].
Slíva J
Vnitr Lek; 2016; 62(9):699-702. PubMed ID: 27715071
[TBL] [Abstract][Full Text] [Related]
72. Influence of G-protein β-Polypeptide 3 C825T Polymorphism on Antihypertensive Response to Telmisartan and Amlodipine in Chinese Patients.
Zhang ZL; Li HL; Wen ZP; Yang GP; Zhang W; Chen XP
Chin Med J (Engl); 2016 Jan; 129(1):8-14. PubMed ID: 26712426
[TBL] [Abstract][Full Text] [Related]
73. Improving hypertension control in patients at cardiovascular risk: the case for telmisartan-based therapy.
Aalbers J
Cardiovasc J Afr; 2011; 22(1):45-6. PubMed ID: 21298207
[No Abstract] [Full Text] [Related]
74. Blood pressure measurement reliability among different racial-ethnic groups in a stroke prevention study.
Estol CJ; Bath PM; Gorelick PB; Cotton D; Martin RH; Weber MA; Dahlof B; ;
Blood Press Monit; 2014 Oct; 19(5):256-62. PubMed ID: 24736279
[TBL] [Abstract][Full Text] [Related]
75. Telmisartan: a review of its use in the management of hypertension.
Battershill AJ; Scott LJ
Drugs; 2006; 66(1):51-83. PubMed ID: 16398568
[TBL] [Abstract][Full Text] [Related]
76. Blood pressure- and pulse pressure-lowering effects, trough:peak ratio and smoothness index of telmisartan compared with lisinopril.
Stergiou GS; Efstathiou SP; Roussias LG; Mountokalakis TD
J Cardiovasc Pharmacol; 2003 Oct; 42(4):491-6. PubMed ID: 14508234
[TBL] [Abstract][Full Text] [Related]
77. Defining blood pressure goals: is it enough to manage total cardiovascular risk?
Mancia G
J Hypertens Suppl; 2009 Jul; 27(5):S3-8. PubMed ID: 19587552
[TBL] [Abstract][Full Text] [Related]
78. Antihypertensive activity of angiotensin II AT1 receptor antagonists: a systematic review of studies with 24 h ambulatory blood pressure monitoring.
Fabia MJ; Abdilla N; Oltra R; Fernandez C; Redon J
J Hypertens; 2007 Jul; 25(7):1327-36. PubMed ID: 17563549
[TBL] [Abstract][Full Text] [Related]
79. Chronic blockade of angiotensin AT₁ receptors improves cardinal symptoms of metabolic syndrome in diet-induced obesity in rats.
Müller-Fielitz H; Hübel N; Mildner M; Vogt FM; Barkhausen J; Raasch W
Br J Pharmacol; 2014 Feb; 171(3):746-60. PubMed ID: 24490862
[TBL] [Abstract][Full Text] [Related]
80. Comparison between L-type and N/L-type calcium channel blockers in the regulation of home blood-pressure variability in elderly hypertensive patients.
Nozato S; Yamamoto K; Nozato Y; Takeda M; Hongyo K; Takeya M; Akasaka H; Takami Y; Takeya Y; Sugimoto K; Ito N; Rakugi H
Hypertens Res; 2018 Apr; 41(4):290-298. PubMed ID: 29449705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]